Global facial injectable market size is expected to exceed USD 18,819.04 Million by 2026, according to the latest research available at Market Study Report LLC, report provides extensively data on market share, growth, trends and forecasts for the period 2018-2026.
Dermal fillers or facial injectable products are important agents for facial transformation. Facial injectables are often used to hide early signs of aging and wrinkles for increasing visual appeal.
According to the report, the facial injectable market is majorly driven by the rising demand to amplify visual attractiveness and burgeoning popularity of minimally invasive surgical procedures. In addition to this, the increase in geriatric population and availability of advanced facial injectables would further advance product demand.
Of late, there has been an upsurge in the demand for non-surgical procedures for facial augmentation across the globe. As per the ISAPS (International Society of Aesthetic Plastic Surgery) 2017, surgical and non-surgical cosmetic procedures depicted an overall spike of 9 percent from past years. The same study also claims that nonsurgical processes including injectable amassed about 8 million across the globe, in 2016.
The report bifurcates the facial injectable market based on end-users, geography, and products. In terms of the product landscape, the global facial injectable market is bifurcated into Anti-wrinkle/Anti-aging Injections and Injectable Implants/Dermal Fillers. The Dermal Fillers are further categorized into Collagen Fillers, Synthetic Fillers, and Hyaluronic Acid. The Anti-aging Injections segment is split into Poly-L-lactic acid micro particles and Botulinum toxin A.
The hyaluronic acid product segment led the global market space in 2017. Additionally, the segment is expected to demonstrate lucrative growth over the projected duration. Surging utilization of hyaluronic acid for dermal filling in cosmetic surgeries is predicted to aid market growth, cites the report.
Moreover, hyaluronic acid possesses robust water retention properties, making it a significant component of aesthetic and cosmetic surgeries. The cosmetic-class hyaluronic acid has low molecular mass which further augments water retention in cells, releases antioxidants, through the product’s deep penetration in the epidermis, and interrupts the aging process.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1695101/
Based on the end user, the market is segmented into Beauty Clinics, Hospitals, Dermatology Clinics, and Dermatology Research Institutes. The findings of the report suggest that the hospital segment was projected to dominate the global facial injectable market, in the year 2017.
The leading players profiled in the global facial injectable market report include Allergan, Plc., ColBar LifeScience Ltd., Galderma Laboratories, L.P., Anika Therapeutics, Inc., Advanced Dermatology, Merz, Inc., Valeant Pharmaceuticals North America LLC., Suneva Medical, Inc., and Sanofi Biosurgery Inc. (Sanofi).
These market behemoths are relying on business tactics such as new product introduction, and partnerships with other known names in the industry, in order to fulfill the unmet clinical as well as aesthetic needs. For instance, Galderma joined forces with Colorescience in 2017, to expand its skincare range which can be used together with conventional facial injectable visual treatments.
In addition, the report also delivers a comprehensive analysis of the facial injectable market drivers, restraints, and opportunities during the projected timeline. A detailed analysis of the market based on the end-user spectrum, products, competitive sphere, and regional landscape is also included in the report.